Controlled substances CME event set for Raleigh: October 25
Categories: Announcements Comments: comments Print Friendly Version | Share this item
The NCMB has partnered with the North Carolina Medical Society and other health care organizations to give licensees the opportunity to participate in high quality continuing medical education on the subject of appropriate opioid prescribing.
Register now to complete SCOPE (Safe and Competent Opioid Prescribing Education) of Pain training, held Friday, October 25, in conjunction with the NCMS Annual Meeting at the Raleigh Marriott City Center. SCOPE of Pain, developed by the Boston University School of Medicine and funded by an unrestricted educational grant from the manufacturers of ER/LA opioid analgesics, is designed to help physicians and other practitioners safely and competently manage patients with chronic pain. The FDA has mandated that manufacturers of extended release/long acting (ER/LA) opioid analgesics make available comprehensive prescriber education in the safe use of these medications, as part of a comprehensive Risk Evaluation and Mitigation Strategy (REMS).
During the afternoon-long program, attendees will learn how to:
The program will also include a panel discussion among national and North Carolina experts on the subject of controlled substances and the treatment of pain.
..........................................................................
What: SCOPE of Pain CME in opioid prescribing
When: Friday, October 25, 12pm-4:15pm
Where: Raleigh Marriott City Center, 500 Fayetteville St., Raleigh
CME: qualifies for 4 AMA PRA Category 1 Credits
Tuition: $25
Register
Register now to complete SCOPE (Safe and Competent Opioid Prescribing Education) of Pain training, held Friday, October 25, in conjunction with the NCMS Annual Meeting at the Raleigh Marriott City Center. SCOPE of Pain, developed by the Boston University School of Medicine and funded by an unrestricted educational grant from the manufacturers of ER/LA opioid analgesics, is designed to help physicians and other practitioners safely and competently manage patients with chronic pain. The FDA has mandated that manufacturers of extended release/long acting (ER/LA) opioid analgesics make available comprehensive prescriber education in the safe use of these medications, as part of a comprehensive Risk Evaluation and Mitigation Strategy (REMS).
During the afternoon-long program, attendees will learn how to:
- Decide on appropriateness of opioid analgesics
- Assess for opioid misuse risk
- Counsel patients about opioid safety, risks and benefits
- Competently monitor patients prescribed opioids for benefit and harm
- Make decisions on continuing or discontinuing opioid analgesics, and
- Safely discontinue opioids when there is too little benefit or too much risk and harm.
The program will also include a panel discussion among national and North Carolina experts on the subject of controlled substances and the treatment of pain.
..........................................................................
What: SCOPE of Pain CME in opioid prescribing
When: Friday, October 25, 12pm-4:15pm
Where: Raleigh Marriott City Center, 500 Fayetteville St., Raleigh
CME: qualifies for 4 AMA PRA Category 1 Credits
Tuition: $25
Register